Health2 years ago
New drug for progressive leukemia provokes ‘impressive’ response
Investigational Menin Inhibitor Levmenib Produces Encouraging Responses in Relapsed or Refractory Patients KMT2A– rearrange or NPM1– Mutant acute leukemia in first-in-human study of oral formulation. In...
Recent Comments